Abstract
Empyema untreated carries significant mortality. Medical management with tube thoracostomy accompanied by combination therapy with intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase, dornase alpha) has decreased the need for surgical intervention. Most studies on this combination therapy have been done on empyema associated with community acquired pneumonia. A fixed regimen of tPA and DNase has a high cost and carries a small risk of intrapleural hemorrhage. We report on two patients who developed empyema postoperatively. Intrapleural DNase and tPA were administered concurrently at a frequency and duration based upon the clinical response. Both patients had successful outcomes without adverse effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: PLEURA Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
